We are live on ! Find out more
VAXX

Vaxxinity, Inc. Class A Common Stock
VAXX

Delisted

VAXX was delisted on the 8th of May, 2024.

Back to rankings

8 hedge funds and large institutions have $67.8K invested in Vaxxinity, Inc. Class A Common Stock in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

86% less funds holding

Funds holding: 58 → 8 (-50)

99% less capital invested

Capital invested by funds: $8.73M → $67.8K (-$8.66M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 50

Holders
8
Holders Change
-50
Holders Change %
-86.21%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
2
Closed
50
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SWM
Spire Wealth Management
Virginia
+$56.8K
2
XT
XTX Topco
Cayman Islands
+$17.9K

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$2.15M
2
BlackRock
BlackRock
New York
-$1.88M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$1.73M
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$630K
5
State Street
State Street
Massachusetts
-$573K
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
– -$32.2K -44,902 Closed
RhumbLine Advisers
27
RhumbLine Advisers
Massachusetts
– -$32K -44,603 Closed
UBS Group
28
UBS Group
Switzerland
– -$30.7K -42,787 Closed
LNC
29
Lincoln National Corp
Pennsylvania
– -$29.5K -41,070 Closed
BZWA
30
Blue Zone Wealth Advisors
California
– -$29.4K -41,000 Closed
Renaissance Technologies
31
Renaissance Technologies
New York
– -$25K -35,100 Closed
TI
32
Tidal Investments
Wisconsin
– -$23.4K -32,617 Closed
Barclays
33
Barclays
United Kingdom
– -$11.1K -29,833 -100%
TAM
34
Titleist Asset Management
Texas
– -$19.8K -27,649 Closed
New York State Common Retirement Fund
35
New York State Common Retirement Fund
New York
– -$17K -23,642 Closed
AIG
36
American International Group
New York
– -$15.1K -21,003 Closed
Truist Financial
37
Truist Financial
North Carolina
– -$14.9K -20,738 Closed
WS
38
Wedbush Securities
California
– -$14K -20,000 Closed
Invesco
39
Invesco
Georgia
– -$13.5K -18,756 Closed
HighTower Advisors
40
HighTower Advisors
Illinois
– -$13K -17,304 Closed
TBWA
41
Three Bridge Wealth Advisors
California
– -$10.2K -14,178 Closed
Wells Fargo
42
Wells Fargo
California
– -$9.13K -12,731 Closed
TRCT
43
Tower Research Capital (TRC)
New York
– -$9.08K -12,640 Closed
HSBC Holdings
44
HSBC Holdings
United Kingdom
– -$8.83K -12,301 Closed
Cambridge Investment Research Advisors
45
Cambridge Investment Research Advisors
Iowa
– -$9K -12,000 Closed
RJFSA
46
Raymond James Financial Services Advisors
Florida
– -$8.01K -11,170 Closed
IWC
47
Integrated Wealth Concepts
Massachusetts
– -$7.89K -11,000 Closed
Fidelity Investments
48
Fidelity Investments
Massachusetts
– -$6.04K -8,422 Closed
Citigroup
49
Citigroup
New York
– -$5.09K -7,101 Closed
Legal & General Group
50
Legal & General Group
United Kingdom
– -$3.78K -5,269 Closed
1
2
3

VAXX Hedge Fund Activity: Q2 2024 in Review

8 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Vaxxinity, Inc. Class A Common Stock (VAXX) for Q2 2024, worth a combined $67.8K — down 99% from $8.73M a quarter earlier.

Sellers outnumbered buyers: 50 funds closed out of VAXX and 0 opened new positions — a net loss of 50 holders — while 2 trimmed existing stakes and 2 added.

The largest buyer was Spire Wealth Management, adding an estimated $56.8K. The largest seller was Adage Capital Partners, exiting entirely with an estimated $2.15M sold.

  • 8 institutional investors held Vaxxinity, Inc. Class A Common Stock (VAXX) as of Q2 2024, down from 58 in Q1 2024.
  • Funds reported $67.8K of Vaxxinity, Inc. Class A Common Stock stock for Q2 2024, down 99% quarter-over-quarter.
  • 0 funds opened new Vaxxinity, Inc. Class A Common Stock positions in Q2 2024 and 50 closed out, a net change of -50 holders.
  • The largest Vaxxinity, Inc. Class A Common Stock buyer in Q2 2024 was Spire Wealth Management, an estimated $56.8K added.
  • The largest Vaxxinity, Inc. Class A Common Stock seller in Q2 2024 was Adage Capital Partners, an estimated $2.15M sold.

Based on aggregated 13F filings for Q2 2024.